These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30666973)

  • 1. Precision diabetes: Where do we stand today?
    Mohan V; Unnikrishnan R
    Indian J Med Res; 2018 Nov; 148(5):472-475. PubMed ID: 30666973
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes Mellitus: A Perspective on the Post-Insulin Era.
    Kudva YC; Nair KS
    Mayo Clin Proc; 2020 Jan; 95(1):15-21. PubMed ID: 31902410
    [No Abstract]   [Full Text] [Related]  

  • 3. Precision Diabetes Is Slowly Becoming a Reality.
    Mohan V; Radha V
    Med Princ Pract; 2019; 28(1):1-9. PubMed ID: 30685765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision medicine in diabetes.
    Kalra S; Chaudhary S
    J Pak Med Assoc; 2019 Sep; 69(9):1394-1395. PubMed ID: 31511734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of genetic biomarker that could improve the treatment of diabetes.
    Pharmacogenomics; 2009 Aug; 10(8):1217. PubMed ID: 19663665
    [No Abstract]   [Full Text] [Related]  

  • 6. Cystic fibrosis in the era of precision medicine.
    Paranjape SM; Mogayzel PJ
    Paediatr Respir Rev; 2018 Jan; 25():64-72. PubMed ID: 28372929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precision medicine for managing diabetes.
    Klonoff DC
    J Diabetes Sci Technol; 2015 Jan; 9(1):3-7. PubMed ID: 25550409
    [No Abstract]   [Full Text] [Related]  

  • 8. Moving towards a more precise treatment of diabetes.
    Gruber K
    Lancet Diabetes Endocrinol; 2015 Mar; 3(3):171. PubMed ID: 25702247
    [No Abstract]   [Full Text] [Related]  

  • 9. Personalized medicine in diabetes mellitus: current opportunities and future prospects.
    Kleinberger JW; Pollin TI
    Ann N Y Acad Sci; 2015 Jun; 1346(1):45-56. PubMed ID: 25907167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders.
    Hess GP; Fonseca E; Scott R; Fagerness J
    Genet Res (Camb); 2015 Jun; 97():e13. PubMed ID: 26030725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leveraging Genomic Factors to Improve Benefit-Risk.
    Schuck RN; Charlab R; Blumenthal GM
    Clin Transl Sci; 2017 Mar; 10(2):78-83. PubMed ID: 28160443
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic drug monitoring: A patient management tool for precision medicine.
    Jang SH; Yan Z; Lazor JA
    Clin Pharmacol Ther; 2016 Feb; 99(2):148-50. PubMed ID: 26565378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetology between genetics and pharmacology; report from the 36th annual meeting of the German Diabetes Association, May 23-26, 2001 at Aachen].
    Stiefelhagen P
    Internist (Berl); 2001 Oct; 42(10):1428-31. PubMed ID: 11702743
    [No Abstract]   [Full Text] [Related]  

  • 14. Precision diabetes: a realistic outlook on a promising approach.
    Marshall SM
    Diabetologia; 2017 May; 60(5):766-768. PubMed ID: 28303304
    [No Abstract]   [Full Text] [Related]  

  • 15. Precision Medicine in Pharmacometrics and Systems Pharmacology.
    Li L
    CPT Pharmacometrics Syst Pharmacol; 2017 Mar; 6(3):151-152. PubMed ID: 28276649
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent advances in the genetics of diabetes.
    Pearson ER
    Prim Care Diabetes; 2008 Jun; 2(2):67-72. PubMed ID: 18684425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic Medicine in Primary Care.
    Hajek C
    S D Med; 2017 Spec; Spec No():62-65. PubMed ID: 28817866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can Epigenetics of Endothelial Dysfunction Represent the Key to Precision Medicine in Type 2 Diabetes Mellitus?
    Coco C; Sgarra L; Potenza MA; Nacci C; Pasculli B; Barbano R; Parrella P; Montagnani M
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31212911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized precision medicine in extreme preterm infants with transient neonatal diabetes mellitus.
    Kylat RI; Senguttuvan R; Bader MY
    J Pediatr Endocrinol Metab; 2017 May; 30(5):593-596. PubMed ID: 28350539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized medicine switching from insulin to sulfonylurea in permanent neonatal diabetes mellitus dictated by a novel activating ABCC8 mutation.
    Mak CM; Lee CY; Lam CW; Siu WK; Hung VC; Chan AY
    Diagn Mol Pathol; 2012 Mar; 21(1):56-9. PubMed ID: 22306677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.